VCU Massey Cancer Center
V

VCU Health Updates on Extranodal Lymphomas

By VCU Massey Cancer Center FEATURING Victor Yazbeck
By VCU Massey Cancer Center FEATURING Victor Yazbeck
0 views
July 7, 2022
Comments 0
Login to view comments. Click here to Login

Featured Video

24:44
Indy Hematology Review

State of the Art in 2024: Emerging Therapies in Hematologic Malignan…

Feat. R. Birhiray

Featured Video

08:18
Insights from 2023 ASH Annual Meeting

Treatment Strategies for Hematocrit Control in PV

Feat. A. Zhou

Recommended

AUTOPLAY
16:57
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Lymphoma Highlights"

Feat. B. D. Cheson
06:33
Christopher Flowers

FDA Approval of Zanubrutinib in R/R FL: What You Need to Know

27:51
Louisville Hematology Highlights

Summary of Recent Advances in Follicular Lymphoma

Feat. S. Gaballa
13:56
SOHO 2023 Eleventh Annual Meeting

Follicular Lymphoma Management: What Is the New Order?

Feat. B. Kahl
17:07
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Comparative Review of Toxicities and Their…

Feat. M. Minnema
35:24
SOHO Highlights: State of the Art and Next Questions

State of the Art and Next Questions: Aggressive B-Cell Lymphomas

Feat. G. Nowakowski
31:12
UChicago Medicine

Practice-Changing Abstracts in NHL and HL From ASH 2023

Feat. S. Smith
15:14
Icahn School of Medicine at Mount Sinai

Safety Profile of Ruxolitinib in Patients With MF

Feat. D. Tremblay
18:24
Memorial Sloan Kettering Cancer Center

Key Lymphoma Updates From ASH

Feat. P. Torka
19:46
Scripps Health

Management of Indolent NHL

Feat. E. Brem
17:21
Daniel Addison

Cardiovascular Considerations With (Contemporary) BTKi in the Treatm…

19:00
Indy Hematology Review

Waldenstrom’s Macroglobulinemia: Approaching the Newly Diagnosed and…

Feat. S. Treon
09:27
ASH 2022 Conference Coverage

MAJIC-PV Trial: Ruxolitinib vs. Best Available Therapy for PV Intole…

Feat. M. McMullin
37:44
University of Colorado Division of Hematology

Summary and Practice Impacts of Recent Updates in B-Cell Lymphomas

Feat. M. Kamdar
08:28
Bruce D. Cheson

Tazemetostat in R/R FL: Impact of EZH2 Mutational Status on PFS

16:25
Northwestern Medicine Oncology and Hematology

Diagnosis and Goals of Therapy in PV

Feat. B. Stein
06:09
Insights from 2023 ASH Annual Meeting

CLL/SLL: Outcomes of Pts With Richter's Transformation Without …

Feat. A. Kittai
19:20
Mitchell Smith

Treatment Landscape in Follicular Lymphoma

06:51
Insights from 2023 ASH Annual Meeting

Prevalence and Prediction of Ruxolitinib Treatment Emergent Thromboc…

Feat. D. Tremblay
25:23
Indy Hematology Review

When Not to Watch and Wait: Emerging Strategies in the Treatment of …

Feat. M. Williams